Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer

Metabolic disorders can lead to a scarcity or excess of certain metabolites such as glucose, lipids, proteins, purines, and metal ions, which provide the biochemical foundation and directly contribute to the etiology of metabolic diseases. Nonalcoholic fatty liver disease, obesity, and cancer are co...

Full description

Saved in:
Bibliographic Details
Published in:International journal of biological sciences 2019-01, Vol.15 (8), p.1654-1663
Main Authors: Cheng, Can, Zhuo, Songming, Zhang, Bo, Zhao, Xu, Liu, Ying, Liao, Chaoliang, Quan, Jing, Li, Zhenzhen, Bode, Ann M, Cao, Ya, Luo, Xiangjian
Format: Article
Language:English
Subjects:
Abnormalities
Animals
Cancer
Chemical compounds
Deregulation
Disorders
Etiology
Fatty liver
Flavonoids
Humans
Lipid metabolism
Lipid Metabolism - genetics
Lipid Metabolism - physiology
Lipids
Liver
Liver cancer
Liver diseases
Metabolic disorders
Metabolites
Metal ions
Natural products
Neoplasms - immunology
Neoplasms - metabolism
Non-alcoholic Fatty Liver Disease - immunology
Non-alcoholic Fatty Liver Disease - metabolism
Obesity
Obesity - immunology
Obesity - metabolism
Pharmacology
Purines
Review
Terpenes
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c406t-2569b4bf79e68d3b4e9936238e1f62f6768c5dbb7791b8162c4800fa522f654f3
cites
container_end_page 1663
container_issue 8
container_start_page 1654
container_title International journal of biological sciences
container_volume 15
creator Cheng, Can
Zhuo, Songming
Zhang, Bo
Zhao, Xu
Liu, Ying
Liao, Chaoliang
Quan, Jing
Li, Zhenzhen
Bode, Ann M
Cao, Ya
Luo, Xiangjian
description Metabolic disorders can lead to a scarcity or excess of certain metabolites such as glucose, lipids, proteins, purines, and metal ions, which provide the biochemical foundation and directly contribute to the etiology of metabolic diseases. Nonalcoholic fatty liver disease, obesity, and cancer are common metabolic disorders closely associated with abnormal lipid metabolism. In this review, we first describe the regulatory machinery of lipid metabolism and its deregulation in metabolic diseases. Next, we enumerate and integrate the mechanism of action of some natural compounds, including terpenoids and flavonoids, to ameliorate the development of metabolic diseases by targeting lipid metabolism. Medicinal natural products have an established history of use in health care and therapy. Natural compounds might provide a good source of potential therapeutic agents for treating or preventing metabolic diseases with lipid metabolic abnormalities.
doi_str_mv 10.7150/ijbs.33837
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6643217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2267013776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-2569b4bf79e68d3b4e9936238e1f62f6768c5dbb7791b8162c4800fa522f654f3</originalsourceid><addsrcrecordid>eNpdkV9rFTEQxYMotlZf_AAS8EXEW_NnN8m-FKSoFQp9aZ9Dkp3c5rKbrEm20Bc_u7ltLbVPM8z8OMyZg9B7So4l7cnXsLPlmHPF5Qt0SLtu2DCm1Msn_QF6U8qOEC56RV6jA065IJSoQ_TnMoOpM8SKw7xMwZkaUiw4eRxNXbOZsEvzktY4FlxN3kINcYunsIQRz1CNTVMoMw4RxxTN5NJ1GzjsTa23DbuBjMdQwBT4gpOFEtrYxBE7Ex3kt-iVN1OBdw_1CF39-H55erY5v_j56_Tb-cZ1RNQN68VgO-vlAEKN3HYwDFwwroB6wbyQQrl-tFbKgVpFBXOdIsSbnrVl33l-hE7udZfVzjC65rdZ00sOs8m3Opmg_9_EcK236UYL0XFGZRP49CCQ0-8VStVzKA6myURIa9GMCUkol1I09OMzdJfW3H5zR6meioHuqc_3lMuplAz-8RhK9D5WvY9V38Xa4A9Pz39E_-XI_wItq6D1</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2268516916</pqid></control><display><type>article</type><title>Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Cheng, Can ; Zhuo, Songming ; Zhang, Bo ; Zhao, Xu ; Liu, Ying ; Liao, Chaoliang ; Quan, Jing ; Li, Zhenzhen ; Bode, Ann M ; Cao, Ya ; Luo, Xiangjian</creator><creatorcontrib>Cheng, Can ; Zhuo, Songming ; Zhang, Bo ; Zhao, Xu ; Liu, Ying ; Liao, Chaoliang ; Quan, Jing ; Li, Zhenzhen ; Bode, Ann M ; Cao, Ya ; Luo, Xiangjian</creatorcontrib><description>Metabolic disorders can lead to a scarcity or excess of certain metabolites such as glucose, lipids, proteins, purines, and metal ions, which provide the biochemical foundation and directly contribute to the etiology of metabolic diseases. Nonalcoholic fatty liver disease, obesity, and cancer are common metabolic disorders closely associated with abnormal lipid metabolism. In this review, we first describe the regulatory machinery of lipid metabolism and its deregulation in metabolic diseases. Next, we enumerate and integrate the mechanism of action of some natural compounds, including terpenoids and flavonoids, to ameliorate the development of metabolic diseases by targeting lipid metabolism. Medicinal natural products have an established history of use in health care and therapy. Natural compounds might provide a good source of potential therapeutic agents for treating or preventing metabolic diseases with lipid metabolic abnormalities.</description><identifier>ISSN: 1449-2288</identifier><identifier>EISSN: 1449-2288</identifier><identifier>DOI: 10.7150/ijbs.33837</identifier><identifier>PMID: 31360108</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher Pty Ltd</publisher><subject>Abnormalities ; Animals ; Cancer ; Chemical compounds ; Deregulation ; Disorders ; Etiology ; Fatty liver ; Flavonoids ; Humans ; Lipid metabolism ; Lipid Metabolism - genetics ; Lipid Metabolism - physiology ; Lipids ; Liver ; Liver cancer ; Liver diseases ; Metabolic disorders ; Metabolites ; Metal ions ; Natural products ; Neoplasms - immunology ; Neoplasms - metabolism ; Non-alcoholic Fatty Liver Disease - immunology ; Non-alcoholic Fatty Liver Disease - metabolism ; Obesity ; Obesity - immunology ; Obesity - metabolism ; Pharmacology ; Purines ; Review ; Terpenes</subject><ispartof>International journal of biological sciences, 2019-01, Vol.15 (8), p.1654-1663</ispartof><rights>Copyright BioMed Central 2019</rights><rights>Ivyspring International Publisher 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-2569b4bf79e68d3b4e9936238e1f62f6768c5dbb7791b8162c4800fa522f654f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643217/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643217/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,36989,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31360108$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cheng, Can</creatorcontrib><creatorcontrib>Zhuo, Songming</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Zhao, Xu</creatorcontrib><creatorcontrib>Liu, Ying</creatorcontrib><creatorcontrib>Liao, Chaoliang</creatorcontrib><creatorcontrib>Quan, Jing</creatorcontrib><creatorcontrib>Li, Zhenzhen</creatorcontrib><creatorcontrib>Bode, Ann M</creatorcontrib><creatorcontrib>Cao, Ya</creatorcontrib><creatorcontrib>Luo, Xiangjian</creatorcontrib><title>Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer</title><title>International journal of biological sciences</title><addtitle>Int J Biol Sci</addtitle><description>Metabolic disorders can lead to a scarcity or excess of certain metabolites such as glucose, lipids, proteins, purines, and metal ions, which provide the biochemical foundation and directly contribute to the etiology of metabolic diseases. Nonalcoholic fatty liver disease, obesity, and cancer are common metabolic disorders closely associated with abnormal lipid metabolism. In this review, we first describe the regulatory machinery of lipid metabolism and its deregulation in metabolic diseases. Next, we enumerate and integrate the mechanism of action of some natural compounds, including terpenoids and flavonoids, to ameliorate the development of metabolic diseases by targeting lipid metabolism. Medicinal natural products have an established history of use in health care and therapy. Natural compounds might provide a good source of potential therapeutic agents for treating or preventing metabolic diseases with lipid metabolic abnormalities.</description><subject>Abnormalities</subject><subject>Animals</subject><subject>Cancer</subject><subject>Chemical compounds</subject><subject>Deregulation</subject><subject>Disorders</subject><subject>Etiology</subject><subject>Fatty liver</subject><subject>Flavonoids</subject><subject>Humans</subject><subject>Lipid metabolism</subject><subject>Lipid Metabolism - genetics</subject><subject>Lipid Metabolism - physiology</subject><subject>Lipids</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver diseases</subject><subject>Metabolic disorders</subject><subject>Metabolites</subject><subject>Metal ions</subject><subject>Natural products</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - metabolism</subject><subject>Non-alcoholic Fatty Liver Disease - immunology</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Obesity</subject><subject>Obesity - immunology</subject><subject>Obesity - metabolism</subject><subject>Pharmacology</subject><subject>Purines</subject><subject>Review</subject><subject>Terpenes</subject><issn>1449-2288</issn><issn>1449-2288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpdkV9rFTEQxYMotlZf_AAS8EXEW_NnN8m-FKSoFQp9aZ9Dkp3c5rKbrEm20Bc_u7ltLbVPM8z8OMyZg9B7So4l7cnXsLPlmHPF5Qt0SLtu2DCm1Msn_QF6U8qOEC56RV6jA065IJSoQ_TnMoOpM8SKw7xMwZkaUiw4eRxNXbOZsEvzktY4FlxN3kINcYunsIQRz1CNTVMoMw4RxxTN5NJ1GzjsTa23DbuBjMdQwBT4gpOFEtrYxBE7Ex3kt-iVN1OBdw_1CF39-H55erY5v_j56_Tb-cZ1RNQN68VgO-vlAEKN3HYwDFwwroB6wbyQQrl-tFbKgVpFBXOdIsSbnrVl33l-hE7udZfVzjC65rdZ00sOs8m3Opmg_9_EcK236UYL0XFGZRP49CCQ0-8VStVzKA6myURIa9GMCUkol1I09OMzdJfW3H5zR6meioHuqc_3lMuplAz-8RhK9D5WvY9V38Xa4A9Pz39E_-XI_wItq6D1</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Cheng, Can</creator><creator>Zhuo, Songming</creator><creator>Zhang, Bo</creator><creator>Zhao, Xu</creator><creator>Liu, Ying</creator><creator>Liao, Chaoliang</creator><creator>Quan, Jing</creator><creator>Li, Zhenzhen</creator><creator>Bode, Ann M</creator><creator>Cao, Ya</creator><creator>Luo, Xiangjian</creator><general>Ivyspring International Publisher Pty Ltd</general><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer</title><author>Cheng, Can ; Zhuo, Songming ; Zhang, Bo ; Zhao, Xu ; Liu, Ying ; Liao, Chaoliang ; Quan, Jing ; Li, Zhenzhen ; Bode, Ann M ; Cao, Ya ; Luo, Xiangjian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-2569b4bf79e68d3b4e9936238e1f62f6768c5dbb7791b8162c4800fa522f654f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abnormalities</topic><topic>Animals</topic><topic>Cancer</topic><topic>Chemical compounds</topic><topic>Deregulation</topic><topic>Disorders</topic><topic>Etiology</topic><topic>Fatty liver</topic><topic>Flavonoids</topic><topic>Humans</topic><topic>Lipid metabolism</topic><topic>Lipid Metabolism - genetics</topic><topic>Lipid Metabolism - physiology</topic><topic>Lipids</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver diseases</topic><topic>Metabolic disorders</topic><topic>Metabolites</topic><topic>Metal ions</topic><topic>Natural products</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - metabolism</topic><topic>Non-alcoholic Fatty Liver Disease - immunology</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Obesity</topic><topic>Obesity - immunology</topic><topic>Obesity - metabolism</topic><topic>Pharmacology</topic><topic>Purines</topic><topic>Review</topic><topic>Terpenes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Can</creatorcontrib><creatorcontrib>Zhuo, Songming</creatorcontrib><creatorcontrib>Zhang, Bo</creatorcontrib><creatorcontrib>Zhao, Xu</creatorcontrib><creatorcontrib>Liu, Ying</creatorcontrib><creatorcontrib>Liao, Chaoliang</creatorcontrib><creatorcontrib>Quan, Jing</creatorcontrib><creatorcontrib>Li, Zhenzhen</creatorcontrib><creatorcontrib>Bode, Ann M</creatorcontrib><creatorcontrib>Cao, Ya</creatorcontrib><creatorcontrib>Luo, Xiangjian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of biological sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Can</au><au>Zhuo, Songming</au><au>Zhang, Bo</au><au>Zhao, Xu</au><au>Liu, Ying</au><au>Liao, Chaoliang</au><au>Quan, Jing</au><au>Li, Zhenzhen</au><au>Bode, Ann M</au><au>Cao, Ya</au><au>Luo, Xiangjian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer</atitle><jtitle>International journal of biological sciences</jtitle><addtitle>Int J Biol Sci</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>15</volume><issue>8</issue><spage>1654</spage><epage>1663</epage><pages>1654-1663</pages><issn>1449-2288</issn><eissn>1449-2288</eissn><abstract>Metabolic disorders can lead to a scarcity or excess of certain metabolites such as glucose, lipids, proteins, purines, and metal ions, which provide the biochemical foundation and directly contribute to the etiology of metabolic diseases. Nonalcoholic fatty liver disease, obesity, and cancer are common metabolic disorders closely associated with abnormal lipid metabolism. In this review, we first describe the regulatory machinery of lipid metabolism and its deregulation in metabolic diseases. Next, we enumerate and integrate the mechanism of action of some natural compounds, including terpenoids and flavonoids, to ameliorate the development of metabolic diseases by targeting lipid metabolism. Medicinal natural products have an established history of use in health care and therapy. Natural compounds might provide a good source of potential therapeutic agents for treating or preventing metabolic diseases with lipid metabolic abnormalities.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher Pty Ltd</pub><pmid>31360108</pmid><doi>10.7150/ijbs.33837</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1449-2288
ispartof International journal of biological sciences, 2019-01, Vol.15 (8), p.1654-1663
issn 1449-2288
1449-2288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6643217
source Publicly Available Content Database; PubMed Central
subjects Abnormalities
Animals
Cancer
Chemical compounds
Deregulation
Disorders
Etiology
Fatty liver
Flavonoids
Humans
Lipid metabolism
Lipid Metabolism - genetics
Lipid Metabolism - physiology
Lipids
Liver
Liver cancer
Liver diseases
Metabolic disorders
Metabolites
Metal ions
Natural products
Neoplasms - immunology
Neoplasms - metabolism
Non-alcoholic Fatty Liver Disease - immunology
Non-alcoholic Fatty Liver Disease - metabolism
Obesity
Obesity - immunology
Obesity - metabolism
Pharmacology
Purines
Review
Terpenes
title Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T01%3A44%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20implications%20of%20natural%20compounds%20targeting%20lipid%20metabolism%20in%20nonalcoholic%20fatty%20liver%20disease,%20obesity%20and%20cancer&rft.jtitle=International%20journal%20of%20biological%20sciences&rft.au=Cheng,%20Can&rft.date=2019-01-01&rft.volume=15&rft.issue=8&rft.spage=1654&rft.epage=1663&rft.pages=1654-1663&rft.issn=1449-2288&rft.eissn=1449-2288&rft_id=info:doi/10.7150/ijbs.33837&rft_dat=%3Cproquest_pubme%3E2267013776%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c406t-2569b4bf79e68d3b4e9936238e1f62f6768c5dbb7791b8162c4800fa522f654f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2268516916&rft_id=info:pmid/31360108&rfr_iscdi=true